PHARMACEUTICAL PREPARATIONS

摘要

RAN 4071/31 The use of compounds of the formula wherein R is hydrogen or a residue -SO3M; M is a cation; and R' and R" are hydrogen or an .alpha.-glycosidically linked sulphated mono- or disaccharide residue; and at least one -SO3M group is present per monosaccharide unit, for the manufacture of pharmaceutical preparations for the prevention and/or treatment of arteriosclerotic disorders and for the prevention of restenoisis after invasive vascular surgery and after organ transplants.